News

Moderna announces first participant dosed in NIH-led Phase 1 study of mRNA Vaccine (mRNA-1273) against Novel Coronavirus

mRNA-1273 is Moderna’s 10th infectious disease vaccine to begin a clinical trial

Mar 17, 2020

By : Team ABLE

Aladdin Healthcare Technologies SE signs MOU with partner in India to validate and distribute COVID-19 diagnosis prototype

Aladdin Healthcare Technologies has signed an MoU with OurHealthMate India (OHM) to validate and distribute its COVID-19 diagnosis prototype through their industry network.

Mar 17, 2020

By : Team ABLE

Pfizer and BioNTech to co-develop potential COVID-19 vaccine

Both Companies will jointly develop BioNTech’s mRNA-based vaccine candidate BNT162 to prevent COVID-19 infection

Mar 17, 2020

By : Team ABLE

PM proposes to set up COVID-19 Emergency Fund for SAARC countries

Prime Minister Modi has proposed creation of a COVID-19 Emergency Fund based on voluntary contributions from all the countries, with India making an initial offer of US$10 million for the fund.

Mar 16, 2020

By : Team ABLE

Research and New Methods of Cancer Treatment– An update by ICMR

A population level initiative for prevention, control and screening for common Non-Communicable Diseases (NCDs) i.e. diabetes, hypertension and common cancers viz. oral, breast and cervical cancer.

Mar 16, 2020

By : Team ABLE